Welcome to the fourth Cancer Crosslink Sweden
October 19, 2016, at Medicon Village, Lund
By bringing together researchers from healthcare providers, academia, and industry with representatives from regulatory units in a one-day meeting, we want to start an interdisciplinary discussion that could lead to new partnerships to develop the area of Personalized Medicine and Immuno-oncology.
The concept of Cancer Crosslink meetings was established in Oslo, Norway, nine years ago when Oslo Cancer Cluster in collaboration with Bristol-Myers Squibb arranged the first Cancer Crosslink meeting. Since then, initiatives to Crosslink meetings has been taken both in Sweden and Finland.
For more information on the conference and preliminary program: http://www.delegia.com/app/attendee/default.asp?ProjectId=7721&PageId=45492